GB Sciences, Inc. (OTCMKTS:GBLX – Get Free Report) was the recipient of a significant increase in short interest in the month of July. As of July 15th, there was short interest totaling 10 shares, an increase of ∞ from the June 30th total of 0 shares. Based on an average trading volume of 53,818 shares, the short-interest ratio is presently 0.0 days.
GB Sciences Stock Performance
OTCMKTS:GBLX traded up $0.00 on Wednesday, hitting $0.00. 1,355 shares of the stock were exchanged, compared to its average volume of 33,864. GB Sciences has a fifty-two week low of $0.00 and a fifty-two week high of $0.01.
About GB Sciences
GB Sciences, Inc is a biotechnology company focused on the research, development and commercialization of cannabinoid-based medicines. Leveraging both botanical and synthetic approaches, the company aims to create novel therapies targeting oncology, neurology and inflammatory diseases. Through its proprietary drug discovery platform, GB Sciences seeks to identify and advance lead compounds that harness the therapeutic potential of cannabinoids while ensuring high standards of quality and safety.
The company operates a cGMP-compliant research and manufacturing facility in Irvine, California, and maintains partnerships to support cultivation and extraction activities in select geographies.
Featured Stories
- Five stocks we like better than GB Sciences
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for GB Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GB Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
